Liquidia Corporation Common Stock vs Southern Company — how do they compare? Liquidia Corporation Common Stock trades at $33.5 (market cap $2.40B), while Southern Company trades at $90.32 (market cap $101.36B). The key difference: Southern Company is far larger — about 42.2× Liquidia Corporation Common Stock's market cap, and Southern Company pays a 3.45% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Southern Company for 17 Days on average.
| LQDA | SO | |
|---|---|---|
Market Cap | $2.40B | $101.36B |
Volume | 2,857,547 | 6,566,089 |
Sector | Health | Utilities |
52-Week High | $91.03 | $99.72 |
52-Week Low | $22.02 | $82.35 |
Typical Hold Time | 0 Days | 17 Days |
Enterprise Value | $2.30B | $175.46B |
Dividend Yield | — | 3.45% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Southern Company (SO) trades at $88.11, up 1.23% on the day, with a mixed technical outlook showing a bullish overall signal but bearish oscillators. The company reported strong Q1 and Q2 2026 earnings beats, with Q3 2026 results pending. Revenue and net income are projected to grow in 2026, supported by a 15.43% net income margin. Analyst sentiment is cautious with a 32.35% buy rating, but the consensus price target of $96.38 suggests upside potential. Recent news highlights data center demand and dividend stability, though near-term cash flow pressure from high capital expenditures is a concern.
The outlook for SO is balanced, with long-term growth driven by utility demand and data center contracts, but near-term risks include capital expenditure pressures and potential data breach impacts. The stock offers a stable dividend and is positioned for gradual appreciation if earnings continue to outperform, yet investors should monitor cash flow trends and regulatory developments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Southern Company is a U.S. energy company with electric and gas utility businesses. Its power generation portfolio includes natural gas, nuclear, renewable, and other energy sources.
Read more on SO →